Navigation Links
National Survey Shows Most Women Are Not Satisfied With Their Progesterone Treatment
Date:11/12/2007

First New Progesterone Supplement in a Decade Debuts As a More Convenient

Treatment

PARSIPPANY, N.J., Nov. 12 /PRNewswire/ -- According to a nationwide survey of 350 women conducted on the American Fertility Association (AFA) Web site, few women undergoing an Assisted Reproductive Technology (ART) treatment for infertility, such as in vitro fertilization (IVF), realize that as they approach the finish line comes another treatment -- progesterone supplementation. This extra boost of progesterone, which supports embryo implantation and early pregnancy, is extremely important for a successful pregnancy. The survey, Progesterone Therapy: The Patient Perspective, was supported by an educational grant from Ferring Pharmaceuticals.

"Progesterone supplementation is a rigorous process that women in ART treatments must undergo for up to 10 weeks to improve their chances of pregnancy," said Pamela Madsen, AFA Executive Director. "One clear and disturbing conclusion from the survey is that there should be far more dialog between patients and their doctor about this critical aspect of treatment and the various therapy choices."

Progesterone Therapy: The Patient Perspective

Surprisingly, many patients did not know about progesterone therapy and product options before they started treatment. For 44 percent, their doctor or nurse did not explain progesterone therapy. Nearly all (94 percent) said they had no input into the selection of a product. Typically, they use whatever the doctor recommends.

Most of the women surveyed (86 percent) were not completely satisfied with their progesterone treatment, and 80 percent feel there is a need for a more patient-friendly option. Nearly all said that if they knew there was a new product available that was just as effective as current therapies, but more comfortable and convenient, they would ask their doctor about it.

The majority (nearly two-thirds) used intramuscul
'/>"/>

SOURCE Ferring Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
4. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
5. The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank
6. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
7. Arrow International Files and Mails Definitive Proxy Materials
8. Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software
9. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
10. Viragen International to Reverse Split Its Common Stock
11. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...4,2009/PRNewswire-FirstCall/--ArenaPharmaceuticals...isscheduledtopresentatthePiperJaffray21stAnnualHea...nTime(8:30a.m.PacificTime)attheNewYorkPalaceHoteli...ecutiveOfficer,isscheduledtoprovideanoverviewofthe...yprograms. ,, Aliveaudiowebcastofthepresentatio...
(Date:11/24/2009)... Chemical Abstracts Service (CAS), the global e...s patent office is now the world,s leading produce...hina trailed Japan,s patent office, the World Inte...ted States Patent and Trademark Office (USPTO) for... WIPO in 2006, and exceeded Japan for the first ti...
(Date:11/23/2009)...omises ultra-fast communication, computation and m.... But trying to use quantum states as carriers of ... two physicists have shown, mathematically, how to...ication, while keeping the information intact. The...cal Review Letters and highlighted with a Viewpoi...
(Date:11/23/2009)...Nov.23/PRNewswire-FirstCall/--NeogenCorporation(Na...D.,waselectedtoNeogen,sBoardofDirectorsatthecompan...rhasmorethan40yearsofexperienceinthefood,agricultu...professorofagriculturaleconomicsatVirginiaTechUniv...dStateschiefagriculturenegotiatorwiththerankofamba...
Breaking Biology Technology:Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Richard T. Crowder Joins Neogen's Board of Directors 2
...DON, November 6 AIM-quoted drug discovery,company...rtant step forward,in the planned development of i...Company,s novel anti-asthmatic compound, RPL554, i...tion toxicology study in another species,in order ...f of concept,clinical trials early next year. RPL...
...PEL HILL, N.C., and VALAIS, Switzerland, Nov. 5 ,L...e signing of a licensing,agreement with a subsidia...ment, marketing, and manufacture of a Dry Eye Synd...ed formulation containing sodium,hyaluronate and i...y a,subsidiary of Lantibio. An ongoing multi-cente...
...NBURY, N.J., Nov. 5 Palatin Technologies,Inc. (Am... year 2008,financial results on November 9, 2007 b... Company will also conduct a teleconference and li...agement team on November 9, 2007 at which,they wil...ail and provide,an update on corporate development...
Other Biology Technology:AIM-Quoted Verona Pharma Progresses Anti-Asthma Drug Studies 2Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 2Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 3Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 4Palatin Technologies to Report Fiscal Year 2008 First Quarter Results; Teleconference and Webcast on November 9, 2007 2
(Date:11/23/2009)..., Calif. -- More than 160 participants gathered th...Keck FUTURES INITIATIVE conference. This year,s to...sts, engineers, and medical researchers to explore...rrounding the emerging field of synthetic biology....logy at Princeton University and this year,s confe...
(Date:11/23/2009)..., Iowa - The only swine vaccine available for the ... infected with the virus. The vaccination marks th... diagnosed with the pandemic flu., Iowa State Un...e, developed the vaccine this summer and has been ...wa, Kansas and Illinois for several weeks., The ...
(Date:11/23/2009)...RMINGHAM, Ala. A new study by University of Alaba...-mass index (BMI) and co-existing medical conditio...vival observed among African-Americans compared to...is published online Nov. 23 in Cancer , a journal...ndicates that although BMI and co-morbidity are in...
Breaking Biology News(10 mins):Synthetic biology offers new opportunities for interdisciplinary collaboration 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Sysmex America Receives Highest Vendor Designation from MedAssets Supply Chain Systems 51679 1Sysmex America Receives Highest Vendor Designation from MedAssets Supply Chain Systems 51679 2Addiction scientists call for end to executions for drug offenders 51675 1Leading Senior Care Destination TheCaringSpace com Launches ElderCare Library and Care Community 51670 1Leading Senior Care Destination TheCaringSpace com Launches ElderCare Library and Care Community 51670 2
...Allergy and Infectious Diseases (NIAID), part of t...unced that enrollment into a large international H...therapy with episodic drug treatment guided by lev... stopped because those patients receiving episodic... (the development of clinical AIDS or death), the ...
...nstitutet in Sweden have helped to identify a mole...st growing cancer tumours. Although the results ar...o new methods of treating metastases. , The result...igious scientific journal Nature Medicine, and rep... KI and Leiden University Medical Centre in Hollan...
...mber, letter or other shape, neurons in various ar...ent components of that shape, almost instantaneous...n image that the individual then "sees" and unders... report. , A team from the university,s Zanvyl Kri...t speedy process in detail in a recent issue of th...
Other Biology News:International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy 2International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy 3International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy 4In the mind's eye: How the brain makes a whole out of parts 2
Mini-blot Trays from Bio-Rad
... supply are used for submerged horizontal gel elec... Model 96 cell includes a buffer tank, a 25 x 10 c...and a gel caster. The PowerPac basic power supply,...V, 4-400 mA, and 75 W. Power cord and instructions...
... over traditional electrophoresis for DNA quantita...sis, and size polymorphisms analysis. The easy-to...for basic research, method development, and qualit...lectrophoresis (CE) systems offer the ruggedness t...
... System uses revolutionary technology to automate ...e protein electrophoresis and immunofixation/subtr...te analysis. The system is truly automated, requir...o process patient samples. The Paragon CZE 2000 pr...
Biology Products: